Before I forget, I distinctly recall Dr Maiti from MD Anderson in a zoom presentation saying that if we get a 20%+ improvement over standard of care in front line, we should qualify for a breakthrough designation from the FDA!!
I also distinctly recall Dr Maiti saying that MD Anderson were involved in 7 out of the last 10 FDA approved therapies for AML....so they will know exactly what GOOD LOOKS LIKE!
Ann: ADVENT-AML Phase 1B clinical trial update, page-20
Add to My Watchlist
What is My Watchlist?
